104 related articles for article (PubMed ID: 17882997)
1. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
[TBL] [Abstract][Full Text] [Related]
2. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
Singh S; Kumari V; Singh N
Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
[TBL] [Abstract][Full Text] [Related]
3. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
Mondal D; Nasrin KN; Huda MM; Kabir M; Hossain MS; Kroeger A; Thomas T; Haque R
PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957193
[TBL] [Abstract][Full Text] [Related]
4. Post kala-azar dermal leishmaniasis: A threat to elimination program.
Gedda MR; Singh B; Kumar D; Singh AK; Madhukar P; Upadhyay S; Singh OP; Sundar S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008221. PubMed ID: 32614818
[TBL] [Abstract][Full Text] [Related]
5. Antimony susceptible
Ghosh S; Verma A; Kumar D; Deep DK; Ramesh V; Salotra P; Singh R
Microbiol Spectr; 2024 May; ():e0402623. PubMed ID: 38712926
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the Long-Term Effectiveness of Miltefosine in Indian Post-Kala-Azar Dermal Leishmaniasis.
Roy S; Moulik S; Roy M; Ghosh MK; Chaudhuri SJ; Pandey DK; Jain S; Dagne DA; Chatterjee M
Am J Trop Med Hyg; 2024 Apr; 110(4):656-662. PubMed ID: 38442428
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis.
Kumar R; Pai K; Pathak K; Sundar S
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1220-4. PubMed ID: 11687466
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Sweat-Based Diagnosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis.
Topno RK; Shankar V; Dikhit MR; Madhukar M; Pandey K; Das VNR; Kumar M; Kumar B; Agrawal K; Siddiqui NA; Sahoo GC; Kumar R; Singh AK; Kumar R; Singh D; Das P
Am J Trop Med Hyg; 2018 Nov; 99(5):1162-1164. PubMed ID: 30203740
[TBL] [Abstract][Full Text] [Related]
9. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
Singh-Phulgenda S; Kumar R; Dahal P; Munir A; Rashan S; Chhajed R; Naylor C; Maguire BJ; Siddiqui NA; Harriss E; Rahi M; Alves F; Sundar S; Stepniewska K; Musa A; Guerin PJ; Pandey K
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0011635. PubMed ID: 38626228
[TBL] [Abstract][Full Text] [Related]
10. Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis.
El Hassan AM; Khalil EA; Elamin WM; El Hassan LA; Ahmed ME; Musa AM
Case Rep Med; 2013; 2013():351579. PubMed ID: 23533426
[TBL] [Abstract][Full Text] [Related]
11. Status of B-Lymphocyte Subsets and Their Homing Markers in Patients With Post-Kala-Azar Dermal Leishmaniasis.
Sengupta S; Goswami D; Chakraborty B; Chaudhuri SJ; Ghosh MK; Chatterjee M
Parasite Immunol; 2024 Mar; 46(3):e13031. PubMed ID: 38527908
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
Volpedo G; Pacheco-Fernandez T; Holcomb EA; Cipriano N; Cox B; Satoskar AR
Front Cell Infect Microbiol; 2021; 11():685296. PubMed ID: 34169006
[TBL] [Abstract][Full Text] [Related]
13. A review of non-invasive samples and tools in kala-azar diagnosis and test of cure.
Vijayakumar S; Narayan PK; Kumari S; Ranjan R; Kumar V; Kumar A; Alti D
Exp Parasitol; 2024 Apr; 259():108713. PubMed ID: 38350522
[TBL] [Abstract][Full Text] [Related]
14. Leishmaniasis in Dhaka Medical College-experience of three years.
Amin MR; Fardin J; Noor N; Mallik PK; Tabassum T; Khan MAS; Hasan MJ
Heliyon; 2020 Nov; 6(11):e05414. PubMed ID: 33251349
[TBL] [Abstract][Full Text] [Related]
15. Quantitative monitoring of experimental and human leishmaniasis employing amastigote-specific genes.
Roy M; Sarkar D; Chatterjee M
Parasitology; 2022 Jul; 149(8):1085-1093. PubMed ID: 35535469
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the recent clinical isolates of Indian Kala-azar patients by RAPD-PCR method.
Khanra S; Bandopadhyay SK; Chakraborty P; Datta S; Mondal D; Chatterjee M; Naskar K; Roy S; Manna M
J Parasit Dis; 2011 Oct; 35(2):116-22. PubMed ID: 23024491
[TBL] [Abstract][Full Text] [Related]
17. Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia.
Palić S; Chu WY; Sundar S; Mondal D; Das P; Pandey K; Raja S; Rijal S; Roseboom IC; Hamadeh A; Malik PRV; Beijnen JH; Huitema ADR; Sjögren E; Alves F; Dorlo TPC
J Antimicrob Chemother; 2024 May; ():. PubMed ID: 38727613
[TBL] [Abstract][Full Text] [Related]
18. Retrospective PCR-based species identification of
Dakić Z; Nielsen HV; Pavlović M; Poluga J; Stevanović G; Lavadinović L; Milošević B; Pelemiš M; Urošević A; Jovanović S; Stensvold CR
JMM Case Rep; 2016 Oct; 3(5):e005063. PubMed ID: 28348785
[TBL] [Abstract][Full Text] [Related]
19. The rK39 strip test is non-predictor of clinical status for kala-azar.
Singh DP; Sundar S; Mohapatra TM
BMC Res Notes; 2009 Sep; 2():187. PubMed ID: 19772616
[TBL] [Abstract][Full Text] [Related]
20. Visceral Leishmaniasis in a Twin Pregnancy: A Case Report and Review of the Literature.
Karampas G; Koulouraki S; Daikos GL; Nanou C; Aravantinos L; Eleftheriades M; Metallinou D; Christopoulos P
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
